Custom synthesis and associated studies RR

Ended Awarded Last action

Contract number
75N95018F00001
Awardee
Awarding agency
Obligated
$694,643

Award facts

Opportunity
Contract value 100% obligated
$694,643.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Minneapolis, MN 55455, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00004 · DE-obligate remaining FY19 expiring funds -$33,813
Funding Only Action P00003 · DE-obligate remaining fiscal year 2018 funds for custom synthesis and associated studies RR -$5,706
Supplemental Agreement for work within scope P00002 $86,495
Other Administrative Action P00001 $0
Original award $647,667

About this award

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $694,643.00 Delivery Order contract to the Regents of the University of Minnesota for custom synthesis and associated studies. The contract is a task order under the larger "CRO Support for NCATS Drug Substance Development and Manufacture" indefinite delivery vehicle. The contract does not have a set-aside designation. As a non-profit organization and 1862 land grant college, the Regents of the University of Minnesota will provide research, testing, and program services to support NCATS' mission of accelerating the translation of scientific discoveries into new treatments for patients.

Quick answers

Who was awarded contract 75N95018F00001?

75N95018F00001 was awarded to Regents Of The University Of Minnesota by National Institute on Drug Abuse (National Institutes of Health) on September 17, 2018.

How much is contract 75N95018F00001 worth?

The government has obligated $694,643 on 75N95018F00001.

Which agency awarded contract 75N95018F00001?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95018F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Is contract 75N95018F00001 an order under another contract?

Yes. 75N95018F00001 is a delivery order under HHSN271201700008I, an indefinite delivery contract, on CRO Support for NCATS Drug Substance Development and Manufacture.

Was contract 75N95018F00001 competed?

The extent of competition for 75N95018F00001 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award